Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses’ Health Study and Nurses’ Health Study II
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hirko, Kelly A.
Fortner, Renée T.
Hankinson, Susan E.
Eliassen, A. Heather
Funding for this research was provided by:
National Cancer Institute (UM1 CA176726, R25 CA098566, UM1 CA186107, R01 CA131218, T32 CA009001)
unspecified valid from 2016-06-13